When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Granuloma anular

Last reviewed: 13 Sep 2025
Last updated: 26 Nov 2020

Summary

Definição

História e exame físico

Principais fatores diagnósticos

  • pápulas dérmicas assintomáticas cor de pele ou rosa-forte agrupadas anularmente
Detalhes completos

Outros fatores diagnósticos

  • máculas ou pápulas pequenas em cor de pele, rosa-forte ou marrom
  • nódulos de tecidos moles
  • pápulas perfurantes, lesões ulceradas ou com crostas
  • manchas eritematosas
Detalhes completos

Fatores de risco

  • diabetes mellitus
  • neoplasia hematológica
  • herpes-zóster
  • vírus da imunodeficiência humana (HIV)
  • hepatite
  • hiperlipidemia
  • doença tireoidiana
  • medicações
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • diagnóstico clínico
Detalhes completos

Investigações a serem consideradas

  • biópsia de pele
  • glicemia de jejum
  • testes da função tireoidiana
  • rastreamento lipídico
  • rastreamento de hepatite
  • teste de vírus da imunodeficiência humana (HIV)
Detalhes completos

Algoritmo de tratamento

AGUDA

variante localizada (erupção cutânea anular clássica)

variante generalizada (erupção cutânea macular disseminada)

variante perfurante (lesões com crostas ou ulceração)

variante subcutânea (nódulos macios)

variante tipo mancha (placas eritematosas)

Colaboradores

Autores

Misha Rosenbach, MD

Associate Professor

Dermatology and Internal Medicine

University of Pennsylvania

Philadelphia

PA

Disclosures

MR has received consulting fees from Merck, aTyr Pharma, and Processa Pharma, not related to granuloma annulare. He has received grant support from Processa Pharma, not related to granuloma annulare. MR has received salary support from the AMA/JAMA for his role at JAMA Dermatology as Deputy Editor. MR is an author of references cited in this topic.

Acknowledgements

Dr Misha Rosenbach would like to gratefully acknowledge Dr Susmita Mukherjee, a previous contributor to this topic. SM declares that she has no competing interests.

Peer reviewers

Aisha Sethi, MD

Assistant Professor of Medicine

Associate Residency Program Director

University of Chicago

Chicago

IL

Divulgaciones

AS declares that she has no competing interests.

Robert Herd, MSc, MD, FRCP

Consultant Dermatologist

Department of Dermatology

Nuffield Hospital

Glasgow

UK

Divulgaciones

RH declares that he has no competing interests.

Brenda L. Pellicane, MD

Dermatologist

Wayne State University School of Medicine

Department of Dermatology

Detroit

MI

Divulgaciones

BLP declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Piette EW, Rosenbach M. Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol. 2016 Sep;75(3):457-65. Resumen

Thornsberry LA, English JC 3rd. Etiology, diagnosis, and therapeutic management of granuloma annulare: an update. Am J Clin Dermatol. 2013 Aug;14(4):279-90. Resumen

Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol. 2016 Sep;75(3):467-79. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad